Asked by: Lisa Cameron (Conservative - East Kilbride, Strathaven and Lesmahagow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of adequacy of the current national provision of teenage and young adult psycho-oncology.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The National Health Service Long Term Plan states that where appropriate every person diagnosed with cancer should receive a Personalised Care and Support Plan. All patients, including young cancer patients, will have access to the right expertise and support.
During the COVID-19 pandemic, all personalised care and support has continued by telephone, video, online or by post if face-to-face appointments and group sessions have not been possible.
NHS England and Improvement established a Task and Finish group chaired by Prof Peter Johnson, the National Clinical Director for Cancer, to look at COVID-19 recovery of psychosocial support for people affected by cancer, including psycho-oncology provision. The group included representation from teenage/young adult cancer charities.
The revised Cancer Care Review requirements for GP practices mean patients’ psychosocial support needs will be assessed twice in their first year after diagnosis. This requirement encourages GP practices to have early and supportive conversations with cancer patients about their needs and ensure patients are aware of what help is available.
Asked by: Lisa Cameron (Conservative - East Kilbride, Strathaven and Lesmahagow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the Disabled Children’s Partnership report, Then There Was Silence, published 10 September 2021, what fiscal steps he is taking to tackle the backlog in disabled children’s health and care assessments.
Answered by Gillian Keegan - Secretary of State for Education
On 6 September 2021 we announced an additional £5.4 billion to support the COVID-19 response over the next six months, bringing the total Government support for health services in response to over £34 billion in 2021/22. This includes £2 billion to tackle the elective backlog to reduce waiting times for patients, including disabled children.
This year councils have access to £51.3 billion to deliver their core services, including a £1.7 billion grant for social care. The Government has given over £6 billion in un-ringfenced funding directly to councils to support the immediate and longer-term impacts of COVID-19 spending pressures, including for children’s services.
Asked by: Lisa Cameron (Conservative - East Kilbride, Strathaven and Lesmahagow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many kidney dialysis patients have acquired hospital-borne infections in each of the last five years; and if he will make a statement.
Answered by Edward Argar - Minister of State (Ministry of Justice)
The UK Health Security Agency carries out mandatory enhanced surveillance of infections in adult haemodialysis patients for National Health Service acute Trusts in England, including for Methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia; Methicillin-sensitive Staphylococcus aureus (MSSA) bacteraemia; Clostridium difficile; and Escherichia coli bacteraemia.
This data is published by the UK Renal Registry in their annual report. The most recent annual report to include this data was published in July 2021, covering data to the end of 2019 and is available at the following link: https://ukkidney.org/sites/renal.org/files/publication/file-attachments/23rd_UKRR_ANNUAL_REPORT_0.pdf.
Asked by: Lisa Cameron (Conservative - East Kilbride, Strathaven and Lesmahagow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the finding of the Disabled Children’s Partnership report, Then There Was Silence, published 10 September 2021, that urgent referrals for children’s mental health services, such as serious self-harm or suicide attempts, increased by 60 per cent in the covid-19 pandemic, what fiscal steps he plans to take to ensure that the mental health of disabled children is supported.
Answered by Gillian Keegan - Secretary of State for Education
While we have made no specific financial provision for this group of patients, on 5 March we announced an additional £79 million funding that will be used to significantly expand children’s mental health services in this financial year. This will allow around 22,500 more children and young people, including those with disabilities, to access community health services and 2,000 more to access eating disorder services. It will also allow a faster increase in the coverage of mental health support teams in schools and colleges.
We also remain committed to the ambitions of the NHS Long Term Plan to invest at least an additional £2.3 billion a year into mental health services by 2023/24. This will enable an extra two million people in England, including 345,000 more children and young people, to access National Health Service-funded mental health support.
Asked by: Lisa Cameron (Conservative - East Kilbride, Strathaven and Lesmahagow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the review of Neurodiversity in the Criminal Justice Sector published in July 2021, what steps his Department is taking to provide comprehensive treatment plans for the management of attention deficit hyperactivity disorder among people in the criminal justice system.
Answered by Gillian Keegan - Secretary of State for Education
NHS England NHS Improvement has commissioned the Centre for Mental Health to conduct a mental health needs analysis in all English prisons. This is expected to provide a greater understanding of the mental health and neurodiverse needs of people in prison, including those with attention deficit hyperactivity disorder.
NHS England and NHS Improvement is also working with Her Majesty's Prison and Probation Service in the identification and roll out of a common screening tool, which will assist in identifying people with neurodiverse needs. Many of these will benefit from non-medical adjustments, while, for some, a diagnostic and treatment pathway will be indicated.
A scoping exercise to understand current treatment pathways is planned as part of the review and refresh of the prison mental health service specification, which will be evidence-based, informed by current best practice and reflect developments in the wider health system.
Asked by: Lisa Cameron (Conservative - East Kilbride, Strathaven and Lesmahagow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to Public Health England's 2020 report, Sugar reduction: progress report, 2015 to 2019, what assessment he has made of the potential effect of the launch of the Office for Health Improvement and Disparities on the expected publication date of the final report on the impact of the UK voluntary sugar reformulation programme; and if he will make a statement.
Answered by Maggie Throup
The transfer of the voluntary reduction and reformulation programme from Public Health England to the Office of Health Promotion and Disparities means the expected publication date of the fourth progress report for the sugar reduction programme will be early in 2022.
Asked by: Lisa Cameron (Conservative - East Kilbride, Strathaven and Lesmahagow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the total cost to the NHS of patient transport for in-centre dialysis patients in each of the past five years.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
No such recent estimate has been made. The information is not held in the format requested.
Asked by: Lisa Cameron (Conservative - East Kilbride, Strathaven and Lesmahagow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the (a) health benefits to patients and (b) costs of opening dialysis centres from six to seven days per week; and if he will make a statement.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The average yearly cost per patient (a) in-centre and (b) home-dialysis, including the cost of treatment and management, is below:
The information quoted relates to the National Health Service (NHS) in England only. Devolved Administrations will differ. All costs will be indicative only, as Market Forces Factor (MFF), transport costs, planned outpatient review and non-elective care will differ between patients and provider contracts.
No recent assessment of the cost benefit of home dialysis compared to in-centre has been made. Assessing such cost benefits to the NHS are part of the Renal Services Transformation Programme (RSTP), which commenced by NHS England in 2021. Cost benefit analysis will vary between providers based upon transport costs and existing demand and capacity constraints in local NHS facilities.
As outlined in the March 2021 Getting It Right First Time Programme National Specialty Report for Renal Medicine, there is a strong preference amongst patients for home dialysis. This is why one of the strategic aims of the RSTP is to increase the percentage of patients per centre receiving home therapies to 20%.
No recent estimate of the health benefits to patients or costs of opening dialysis centres from six to seven days per week has been made.
Asked by: Lisa Cameron (Conservative - East Kilbride, Strathaven and Lesmahagow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what his most recent assessment is of the cost benefit to the NHS of the provision of dialysis services in a patient's home compared to dialysis services in-centre.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The average yearly cost per patient (a) in-centre and (b) home-dialysis, including the cost of treatment and management, is below:
The information quoted relates to the National Health Service (NHS) in England only. Devolved Administrations will differ. All costs will be indicative only, as Market Forces Factor (MFF), transport costs, planned outpatient review and non-elective care will differ between patients and provider contracts.
No recent assessment of the cost benefit of home dialysis compared to in-centre has been made. Assessing such cost benefits to the NHS are part of the Renal Services Transformation Programme (RSTP), which commenced by NHS England in 2021. Cost benefit analysis will vary between providers based upon transport costs and existing demand and capacity constraints in local NHS facilities.
As outlined in the March 2021 Getting It Right First Time Programme National Specialty Report for Renal Medicine, there is a strong preference amongst patients for home dialysis. This is why one of the strategic aims of the RSTP is to increase the percentage of patients per centre receiving home therapies to 20%.
No recent estimate of the health benefits to patients or costs of opening dialysis centres from six to seven days per week has been made.
Asked by: Lisa Cameron (Conservative - East Kilbride, Strathaven and Lesmahagow)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the average yearly cost per patient is of (a) in-centre and (b) home-dialysis, including the cost of treatment and management.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The average yearly cost per patient (a) in-centre and (b) home-dialysis, including the cost of treatment and management, is below:
The information quoted relates to the National Health Service (NHS) in England only. Devolved Administrations will differ. All costs will be indicative only, as Market Forces Factor (MFF), transport costs, planned outpatient review and non-elective care will differ between patients and provider contracts.
No recent assessment of the cost benefit of home dialysis compared to in-centre has been made. Assessing such cost benefits to the NHS are part of the Renal Services Transformation Programme (RSTP), which commenced by NHS England in 2021. Cost benefit analysis will vary between providers based upon transport costs and existing demand and capacity constraints in local NHS facilities.
As outlined in the March 2021 Getting It Right First Time Programme National Specialty Report for Renal Medicine, there is a strong preference amongst patients for home dialysis. This is why one of the strategic aims of the RSTP is to increase the percentage of patients per centre receiving home therapies to 20%.
No recent estimate of the health benefits to patients or costs of opening dialysis centres from six to seven days per week has been made.